• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Journal of Invasive Cardiology

  • Follow us on
  • HOME
  • About Us
    • Editorial Board
    • About JIC
    • Impact factor: 1.841
    • Subscribe
    • Contact Us
  • Issues
    • Current Issue
    • Issue Archives
  • Next Month
  • Advertise
  • Reprints
  • Multimedia
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • IAGS
    • 11th Biennial Meeting (2012, Costa Rica)
    • 10th Biennial Meeting (2009, South Africa)
    • 30 Year Anniversary (2008, Zurich)
    • 9th Biennial Meeting (2007, Canouan)
    • 8th Biennial Meeting (2004, Lanai)
    • 7th Biennial Meeting (2002, St. Lucia)
    • 6th Biennial Meeting (2000, Crete)
    • 5th Biennial Meeting (1998, Punta Del Este)
    • 4th Biennial Meeting (1996, Aruba)

Search

Enter multiple addresses separated by commas and/or different lines.
Transcatheter Renal Denervation

CARDIOLOGY BLOG

Which Treatment is Best for Atrial Fibrillation?

Todd J. Cohen M.D.

Healthcare Reform

International Andreas Gruentzig Society

ADAPT and Overcome – Learning to Stop the Guesswork

Scott W. Murray MD

Acute Stroke Intervention: Where Do We Stand?

International Andreas Gruentzig Society

Critical Limb Ischemia and Below Knee PTA

International Andreas Gruentzig Society
more »

Cardiology Events

  • C3: Complex Cardiovascular Catheter Therapeutics
    June 17, 2013 - June 21, 2013
    Orlando, FL, United States
  • NYC TRAC (TransRAdial Course)
    June 28, 2013 - June 29, 2013
    New York, NY, United States
  • Chicago EndoVascular Conference 2013
    July 7, 2013 - July 10, 2013
    Chicago, IL, United States
more »

Invasive Cardiology Newswire

  • Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial
    Wed, 06/19/13 - 2:06pm
  • UMass Memorial Medical Center First in Massachusetts to Implant Bioresorbable Vascular Scaffold for Treatment of Heart Disease
    Tue, 06/18/13 - 12:42pm
  • Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve U.S. Pivotal Trial
    Mon, 06/17/13 - 3:19pm
  • Cordis Announces FDA Clearance of the ADROIT Guiding Catheter
    Thu, 06/13/13 - 10:11am
more »

Supplements

REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications
  • Home
  • About Us
  • Editorial and Advertising Policy
  • Other Publications
  • Terms & Conditions
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications